NEWS/RELEASE

TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan

December 20, 2022

TANAKA Kikinzoku Kogyo K.K. manufacturing business, announced today that it has made an equity contribution to the medical venture capital fund Diamond Medino Capital (DMC) No. 1 Investment Limited Partnership founded in Japan by Professor Terumitsu Hasebe (Professor, Faculty of Medicine, School of Medicine, Tokai University; Visiting Professor, Keio University School of Medicine; Visiting Professor, Massachusetts Institute of Technology/Harvard Medical School; medical doctor, PhD in Medicine, and PhD in Engineering). This is Japan’s first medical venture capital fund established with an active medical professor serving as its representative.

Through this equity contribution, TANAKA Kikinzoku Kogyo will contribute toward technological development in Japan’s domestic medical and healthcare industry.

20221220_TANAKA Contributes to Venture Capital Fund “DMC No. 1 Investment Limited Partnership” Aiming to Establish a Medical Venture Ecosystem in Japan.pdf